The longitudinal LC-MS/MS proteomics analysis of hospitalized COVID-19 patients and symptomatic control serum samples revealed an early decrease in innate immune proteins at the time of hospitalization with an increase in coagulation and lipid metabolism proteins [37]. The gene discussed is PROS1; the disease is COVID-19.